Longterm Effect Of Phenytoin On Lipid Profile Parameters In Epileptic Patients


  • M Beg
  • S Afzaal
  • A Kamal
  • A Amir


Research Problem: What are the factors responsible for decreased incidence of coronary artery disease in epileptics? Objectives: To evaluate the effect of phenytoin on lipid profile parameters in epileptics and to discuss its implications. Study Design: Prospective study. Setting: Neurology clinic of Medicine Department of a teaching hospital. Participants: Randomly selected epileptic patient at­tending neurology clinic and admitted to inpatient department of J. N. Medical College Hospital. Sample Size: 56 epileptic patients. Study Variables: Phenytoin therapy, lipid profile pa­rameters. Statistical Analysis: By test of significance. Result: No significant change in serum levels of total cholesterol, LDL - C, VLDL - C, triglycerides and phospholipids was observed with phenytoin therapy during study. However, serum HDL - C showed a significant increase, both at 12 weeks and 24 weeks ( P < 0.001) of therapy. Conclusion: Phenytoin,    a    commonly used anticonvulsive drug, increases serum HDL - C level significantly, while there is no significant change in other parameters of lipid profile. This rise in HDL - C may provide protection to epileptic patients against atherogenic vascular diseases including coronary ar­tery disease.


Download data is not yet available.




How to Cite

Beg M, Afzaal S, Kamal A, Amir A. Longterm Effect Of Phenytoin On Lipid Profile Parameters In Epileptic Patients. Indian J Community Health [Internet]. 1997 Dec. 31 [cited 2024 Apr. 16];9(3):27-30. Available from: https://iapsmupuk.org/journal/index.php/IJCH/article/view/59



Original Article